Pheton holdings ltd PTHL.US Overview Analysis
PTHL AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
With insufficient quarterly financial data released by the company, we're unable to provide a rating.
PTHL Current Performance
8.29%
Pheton holdings ltd
0.23%
Avg of Sector
0.43%
S&P500
Top 10 High Relevance to PTHL
- OPRX Optimizerx corporationValue 2Trend 5Swing Trading 3Whale Interest 1Dividend 1See more
PTHL Profile
Pheton Holdings Ltd is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company's main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company's main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian's product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.